Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-01 Sale |
2022-12-20 4:05 pm |
Oncocyte Corp | OCX | Paulsen Gisela Former President and COO |
175,000 | $0 | $0 | 624,312 (Direct) |
View |
| 2022-03-17 Purchase |
2022-03-17 9:27 pm |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
16,500 | $1.198 | $19,767 | 266,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-15 Option Award |
2022-08-17 8:22 pm |
N/A N/A |
Oncocyte Corp | OCX | Paulsen Gisela President & COO |
525,000 | $0 | 541,500 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:27 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
250,000 | $0 | 266,500 (Direct) |
View |
Ownership |
2021-10-14 4:05 pm |
N/A 2031-10-04 |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
0 | $0 | 375,000 (Direct) |
View |